SCHEMBL7532828

SCHEMBL7532828

N#Cc1cccc2c(CCN3CCN(c4cccc5[nH]ccc45)CC3)c[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.51
HTR2A P28223 3/20 0.51
HTR1A P08908 2/20 0.51
HTR7 P34969 1/20 0.49
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
GAA P10253 2/20 0.47
MAPT P10636 1/20 0.47
ABCC1 P33527 5/20 0.47
ABCB1 P08183 2/20 0.45
ABCG2 Q9UNQ0 2/20 0.45
HTR6 P50406 2/20 0.45
KCNH2 Q12809 2/20 0.45
GOT1 P17174 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532665 0.85 DRD2 (0.52) DRD2HTR2AHTR1AHTR7DRD4
SCHEMBL7539032 0.85 DRD2 (0.57) DRD2HTR2AHTR1AHTR7DRD4
SCHEMBL7532948 0.84 DRD2 (0.66) DRD2HTR2AHTR1AHTR7DRD4
SCHEMBL26508415 0.80 HTR2A (0.57) HTR2AHTR1AHTR7DRD4ABCC1
SCHEMBL7532686 0.78 DRD2 (0.59) DRD2HTR2AHTR1AHTR7ABCC1
SCHEMBL7532701 0.78 HTR1A (0.72) DRD2HTR1A
SCHEMBL7538925 0.77 DRD2 (0.68) DRD2HTR1A
SCHEMBL7532842 0.76 HTR6 (0.62) DRD2HTR2AHTR1AHTR7DRD4
SCHEMBL7534561 0.76 HTR1A (0.70) DRD2HTR1AHTR7HTR6KCNH2
SCHEMBL7535043 0.76 DRD2 (0.60) DRD2HTR2AHTR1AHTR7DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128272-A1 4,5,6, and 7-indole and indoline derivatives, their preparation and use H. LUNDBECK A/S (DK) 2002-09-12 US claimed
US-6391882-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS H. LUNDBECK A/S (DK) 2002-05-21 US claimed
CN-1336925-A 4,5,6 and 7-indole and indoline derivatives, their prepn. and use LUNDBECK & CO AS H (DK) 2002-02-20 CN claimed
EP-1089997-A1 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE H.Lundbeck A/S (DK) 2001-04-11 EP claimed
WO-1999067237-A1 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 1999-12-29 WO claimed
US-20020128272-A1 4,5,6, and 7-indole and indoline derivatives, their preparation and use H. LUNDBECK A/S (DK) 2002-09-12 US disclosed
US-6391882-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS H. LUNDBECK A/S (DK) 2002-05-21 US disclosed
CN-1336925-A 4,5,6 and 7-indole and indoline derivatives, their prepn. and use LUNDBECK & CO AS H (DK) 2002-02-20 CN disclosed
EP-1089997-A1 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE H.Lundbeck A/S (DK) 2001-04-11 EP disclosed
WO-1999067237-A1 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 1999-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128272-A1 4,5,6, and 7-indole and indoline derivatives, their preparation and use HTR2C, HTR1A, HTR7 DRD2 49/4885HTR2A 6/4885HTR1A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.